Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1163 results for "usfda"

Zydus Cadila gets USFDA nod for chemotherapy drug
Money Control

FDA nod for anti-migraine drug to lift US revenues: Panacea

The company Wednesday received the US Food and Drug Administration (USFDA) approval for an anti-migraine drug for which it had filed the Abbreviated New Drug Application (ANDA) in 2012. Money Control, 3 days ago
Zydus Cadila receives USFDA approval India Infoline, 4 days ago

218 images for usfda

Money Control, 4 days ago
Money Control, 4 days ago
Deccan Chronicle, 1 week ago
Money Control, 1 week ago, 1 week ago
Money Control, 1 week ago
India Infoline, 4 days ago, 1 week ago
Deccan Chronicle, 2 weeks ago
Odisha Television, 2 weeks ago
Money Control

Panacea Biotec zooms nearly 18% on USFDA nod for migraine drug

Shares of Panacea Biotec today surged nearly 18 per cent after the company inked a pact with UNICEF for supply of Pentavalent Vaccine (Easyfive-TT) in the current year and got approval from the US health regulator for migraine drug. The stock zoomed 17.70 per ...
 Business Standard4 days ago Panacea inks pact with UNICEF,gets USFDA nod for migraine drug  Money Control4 days ago Panacea inks pact with UNICEF, gets USFDA nod for migraine drug  Business Line4 days ago

Panacea Biotec trades jubilantly on getting USFDA's approval for Rizatriptan Benzoate Tablet

SENSEX 27226.11 9.55 0.04% NIFTY 8410.65 12.65 0.15% Industry: Medical/Healthcare Company Panacea Biotec Ltd Panacea Biotec is currently trading at Rs. 142.60, up by 16.35 points or 12.95% from its previous closing of Rs.
 Finalaya.com4 days ago Panacea Biotec gets USFDA's approval for Rizatriptan Benzoate Tablet  Finalaya.com4 days ago

Panacea Biotec zooms 18% on USFDA approval for migraine drug

Panacea Biotec has zoomed 18% to Rs 149, also its 52-week high on the National Stock Exchange (NSE) in noon deal after the pharmaceutical company announced that it has receive the US regulator's approval for making a migraine drug. The US Food and ...
 Smart Investor4 days ago

Indian American on Trump probables list for USFDA chief

Indian American Balaji Srinivasan is said to be on US President-elect Donald Trumps list of probables for the top job at the regulatory Food and Drugs Administration (FDA). Srinivasan met Trump last week, a person close to the development said, confirming ...
 Business Line5 days ago Indian-American Entrepreneur Under Consideration To Lead USFDA  NDTV5 days ago
Money Control

USFDA to re-inspect Dr Reddy's plants by March

The company received a warning letter from the USFDA on November 5, 2015, for specific violations
 Business Standard1 week ago Plants of Pharma major, Dr. Reddy's to be re-audited by USFDA  India Infoline1 week ago USFDA to re-audit three Dr Reddy's plants  Money Control1 week ago USFDA to re-audit Dr Reddy's Laboratories manufacturing facilities  Livemint.com1 week ago

Divis Laboratories provides update on USFDA inspection of Visakhapatnam unit

Files detailed response to Form 483 observations
 Business Standard1 week ago Divis Lab: Update on USFDA inspection of Unit-II at Visakhapatnam  Money Control1 week ago Sun Pharmaceutical Industries provides business update  Business Standard1 month ago Granules Indian provides update on USFDA inspection of Granules OmniChem's Vizag facility  Business Standard1 month ago

Biocon at new high as USFDA accepts application for cancer drug

Biocon shares touched a record high of Rs 1,049.50 on Thursday, up nearly 5 percent intraday after the US health regulator has accepted biosimilar application for its proposed cancer drug.
 Money Control1 week ago Biocon hits new high after USFDA accepts cancer drug biosimilar application  Smart Investor1 week ago Biocon hits 52-week high on USFDA nod to cancer drug application  Religare Securities1 week ago Caplin up 7% after USFDA inspection of sterile injectable unit  Money Control2 months ago

Biocon up 3% as USFDA accepts Trastuzumab license application

Biocon Limited bucked the downward trend in the pharma stocks on Thusday and was trading up over 3% in early trade after the US Food and Drug Administration (USFDA) had accepted Mylan's biologics license application for MYL-1401O, a proposed biosimilar ...
 DNA1 week ago BRIEF-Biocon Ltd says USFDA accepts BLA for Mylan & co's proposed biosimilar trastuzumab  Reuters UK1 week ago USFDA accepts Mylan's BLA for proposed biosimilar Trastuzumab  Sudan News Gazette1 week ago

USFDA to review Biocon-Mylan's biosimilar drug for breast cancer

Bengaluru-based biopharmaceutical firm Biocon on Wednesday said US drug regulator has accepted its partners Mylan’s biologics license application (BLA) for the proposed biosimilar of breast cancer drug Trastuzumab through the 351(k) pathway.
 Money Control1 week ago USFDA accepts Biocon cancer drug biosimilar application  Smart Investor1 week ago New Potential Treatment for Breast Cancer Metastasis  MedIndia1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less